Search results for "time factor"

showing 10 items of 3219 documents

Use of covered chimney stents for pararenal aortic pathologies is safe and feasible with excellent patency and low incidence of endoleaks.

2012

Background To present the clinical experience of consecutive series with use of balloon-expandable and self-expanding chimney endografts (balloon-expandable covered stent group [BECS] vs self-expanding covered stent group [SECS]) in the endovascular treatment of challenging aortic pathologies requiring renal and/or visceral revascularization. Methods Between January 2009 and May 2011, data for 37 high-risk patients from one center and 35 patients from another institution, with pararenal aortic pathologies treated by the chimney endovascular technique, were prospectively collected. The chimney-graft technique is based on the deployment of a covered or bare-metal stent parallel to the aortic …

Malemedicine.medical_specialtyTime FactorsEndoleakmedicine.medical_treatmentEVAR aneurysm chimney periscopesAortic Diseases610 Medicine & healthKaplan-Meier EstimateRevascularizationBalloonProsthesis DesignSettore MED/22 - Chirurgia VascolareAortographyRisk Assessment2705 Cardiology and Cardiovascular MedicineBlood Vessel Prosthesis ImplantationPredictive Value of TestsRisk FactorsAngioplastyGermanymedicineHumansVascular PatencyComputed tomography angiographyAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryStentPerioperativemedicine.disease10020 Clinic for Cardiac Surgery2746 SurgerySurgeryBlood Vessel ProsthesisStenosisTreatment OutcomeCuffSurgeryFemaleStentsRadiologyCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedAngioplasty BalloonSwitzerlandJournal of vascular surgery
researchProduct

Combining Sirolimus-eluting Stents and External Irradiation in Cholesterol-fed Rabbits Increased Incomplete Stent Apposition and Decreased Re-endothe…

2009

Restenosis after the implantation of a drug-eluting stent or after vascular irradiation therapy shares similar physiopathological mechanisms. No experimental data are currently available on vascular wall behavior after external irradiation on arteries stented with sirolimus-eluting stents (SES). Ten New Zealand white rabbits received a 0.5% cholesterol-enriched chow for 1 month. Bilateral iliac artery stent implantation was then performed with an SES (Cypher; Cordis Corp). The animals were randomized into either an irradiated group (I, 2 Gy external x-ray irradiation, n = 5) or a control group (C, n = 5). The cholesterol-enriched chow was continued for 1 additional month after stent implant…

Malemedicine.medical_specialtyTime FactorsEndotheliummedicine.medical_treatmentUrologyCholesterol Dietarychemistry.chemical_compoundRestenosismedicineAnimalsSirolimusPharmacologyCholesterolbusiness.industryX-RaysStentDose-Response Relationship RadiationDrug-Eluting StentsIncomplete stent appositionequipment and suppliesmedicine.diseaseImmunohistochemistryPathophysiologySurgeryStenosisCholesterolmedicine.anatomical_structurechemistrySirolimusEndothelium VascularRabbitsTunica IntimaTunica MediaCardiology and Cardiovascular MedicinebusinessImmunosuppressive Agentsmedicine.drugJournal of Cardiovascular Pharmacology
researchProduct

Supervised exercise training in peripheral arterial disease increases vascular shear stress and profunda femoral artery diameter

2016

Background Arteriogenesis is promoted by flow- and pressure-related forces such as tangential wall stress and laminar shear stress. Exercise training (ET) is known to promote arteriogenesis in peripheral arterial disease (PAD) patients. It remains unclear whether supervised ET (SET) promotes arteriogenesis more efficiently than non-SET (nSET). Methods and results Forty PAD patients participated in a SET or nSET training programme ( n = 20 each) and were compared to 20 healthy individuals without any history of cardiovascular events. Femoral artery diameter, flow and velocity were measured by ultrasound. Tangential wall stress and laminar shear stress were calculated for femoral arteries. Fo…

Malemedicine.medical_specialtyTime FactorsEpidemiologyArterial diseaseCollateral CirculationNeovascularization PhysiologicPilot ProjectsWalk TestWalkingFemoral artery030204 cardiovascular system & hematologyArtery morphogenesisPeripheral Arterial Disease03 medical and health sciencesWalking distance0302 clinical medicinemedicine.arteryInternal medicinemedicineShear stressHumansAnkle Brachial Index030212 general & internal medicineAgedUltrasonographyExercise Tolerancebusiness.industryUltrasoundMiddle AgedExercise TherapySurgeryPeripheralFemoral ArteryTreatment OutcomeRegional Blood FlowCase-Control StudiesCardiologyFemaleStress MechanicalArteriogenesisCardiology and Cardiovascular MedicinebusinessEuropean Journal of Preventive Cardiology
researchProduct

Frequency and determinants for hemorrhagic transformation of cerebral infarction.

2009

<i>Background:</i> Frequency and associated risk factors for hemorrhagic transformation (HT), a worrying complication of ischemic stroke (IS), are not clearly defined. Our aim was to estimate the overall frequency and risk factors for HT in a hospital-based population. <i>Methods:</i> A retrospective review of medical records of patients discharged from our department during the period 2004–2006 with a diagnosis of anterior IS. Demographic, clinical and hematological information was collected. Uni- and multivariate logistic regression analyses were used to estimate risk for spontaneous HT. <i>Results:</i> We included 240 patients (125 males, 52%), mean ag…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMEDLINEText miningRisk FactorsEpidemiologyMedicineHumansAgedCerebral HemorrhageRetrospective StudiesAged 80 and overhemorrhagic transformation ischemic strokebusiness.industryCerebral infarctionFollow up studiesRetrospective cohort studyCerebral InfarctionMiddle Agedmedicine.diseaseSurgeryEmergency medicineIschemic strokeFemaleNeurology (clinical)businessComplicationFollow-Up Studies
researchProduct

Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Pat…

2020

Background Risk stratification among patients with coronary artery disease ( CAD ) is of considerable interest due to the potential to guide secondary preventive therapies. Thus, we evaluated the predictive value of soluble urokinase‐type plasminogen activator receptor (su PAR ) levels for cardiovascular mortality and nonfatal myocardial infarction in patients with CAD . Methods and Results Plasma levels of su PAR were measured in a cohort of 1703 patients with documented CAD as evidenced by coronary angiography—including 626 patients with acute coronary syndrome and 1077 patients with stable angina pectoris. Cardiovascular death and/or nonfatal myocardial infarction were defined as main o…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMyocardial InfarctionRenal functionCoronary Artery Disease030204 cardiovascular system & hematologyKidneyRisk AssessmentReceptors Urokinase Plasminogen Activatorsoluble urokinase‐type plasminogen activator receptorTroponin CCoronary artery disease03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsGermanyInternal medicineSecondary PreventionmedicineHumanscardiovascular diseasesMyocardial infarctionReceptorAgedOriginal Research030304 developmental biologyUrokinase0303 health sciencesbusiness.industryMiddle AgedPrognosismedicine.diseaseTroponinC-Reactive ProteinHeart Disease Risk FactorsCardiologybiomarkerBiomarker (medicine)FemaleKidney DiseasesCardiology and Cardiovascular MedicinebusinessPlasminogen activatorBiomarkersGlomerular Filtration Ratemedicine.drugJournal of the American Heart Association
researchProduct

Low Systolic Blood Pressure and Mortality in Elderly Patients After Acute Myocardial Infarction

2020

Background Optimal blood pressure in elderly patients after acute myocardial infarction is still a matter of debate. In a prospective observational study, we aimed to identify optimal systolic blood pressure during the 48 first hours after admission for acute myocardial infarction and its prognostic value for cardiovascular mortality. Methods and Results From the Observatoire des Infarctus de Côte d'Or survey, all consecutive patients aged >75 years admitted for an acute myocardial infarction in a coronary care unit from 2012 to 2015 and discharged alive were included (n=814). Exclusion criteria were in‐hospital death, cardiogenic shock, and end‐stage renal disease. Average systolic blo…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMyocardial Infarctionacute myocardial infarction030204 cardiovascular system & hematologyelderly patientsRisk Assessment03 medical and health sciencesPatient Admission0302 clinical medicinecardiovascular mortalityInternal medicinemedicineCoronary Heart DiseaseHumansProspective Studies030212 general & internal medicineMyocardial infarctionNon-ST Elevated Myocardial InfarctionOriginal ResearchAgedCardiovascular mortalityAged 80 and overbusiness.industryAge Factorsblood pressurePrognosismedicine.diseaseBlood pressureHeart Disease Risk FactorsCardiologyST Elevation Myocardial InfarctionFemaleObservational studyCardiology and Cardiovascular MedicinebusinessJournal of the American Heart Association
researchProduct

Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia

2005

Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) has proven to be safe and effective in patients with early neoplasia in Barrett's esophagus. However, long-term results in patients with high-grade intraepithelial neoplasia (HGIN) or with early cancer are still lacking.The aim of the study was to evaluate the efficacy of ALA-PDT and the survival of patients with early Barrett's neoplasia. ALA-PDT was carried out in 66 patients. Protoporphyrin IX induced by oral administration of ALA (60 mg/kg body weight orally applied 4-6 hours before PDT) was used as the photosensitizer. Acid suppression was maintained in all patients.Between September 1996 and September 2002, 667 patients with …

Malemedicine.medical_specialtyTime FactorsEsophageal Neoplasmsmedicine.medical_treatmentPhotodynamic therapyAdenocarcinomaSeverity of Illness IndexGastroenterologyDisease-Free SurvivalBarrett EsophagusGermanyInternal medicineHumansMedicineRadiology Nuclear Medicine and imagingEsophagusSurvival rateAgedNeoplasm StagingRetrospective StudiesIntraepithelial neoplasiaPhotosensitizing Agentsbusiness.industryGastroenterologyCancerAminolevulinic AcidMiddle Agedmedicine.diseaseSurvival RateTreatment Outcomemedicine.anatomical_structurePhotochemotherapyEsophagectomyHigh Grade Intraepithelial NeoplasiaAdenocarcinomaFemalebusinessPrecancerous ConditionsFollow-Up StudiesGastrointestinal Endoscopy
researchProduct

Pancreatic enzyme therapy in childhood celiac disease. A double-blind prospective randomized study.

1995

The validity of pancreatic enzyme substitution therapy in the two months following diagnosis of celiac disease was investigated. Twenty patients (8 males, 12 females), mean age 14.2 months (group A) received an enzyme substitution preparation. The control group (group B) included 20 patients (9 males, 11 females), mean age 14.5 months, treated with placebo. Before starting treatment, we performed a stratification for age, weight-for-age at diagnosis, and degree of pancreatic insufficiency. The therapies were then administered randomly in double-blind fashion. On diagnosis and 30 and 60 days after commencement of a gluten-free diet with identical calorie intake in both groups, a series of an…

Malemedicine.medical_specialtyTime FactorsGlutensPhysiologyNutritional StatusPlaceboWeight GainGastroenterologyGroup AGroup BCoeliac diseaselaw.inventionRandomized controlled trialDouble-Blind MethodGastrointestinal AgentslawInternal medicinemedicineHumansProspective StudiesProspective cohort studybusiness.industryGastroenterologyInfantmedicine.diseaseCeliac DiseasePancreatic Function Testsmedicine.anatomical_structureChild PreschoolPancreatinFemalemedicine.symptomPancreasbusinessWeight gainDigestive diseases and sciences
researchProduct

The impact of ovarian stimulation on the expression of candidate reprogramming genes in mouse preimplantation embryos.

2012

Ovarian stimulation with gonadotrophins is an integral part of assisted reproductive technologies in human subfertility/infertility treatment. Recent findings have associated ovarian stimulation with the increased incidence of imprinting disorders in humans as well as defects in genome-wide methylation reprogramming and, in particular, imprinting in mice. Here, we present the first study that determined the impact of ovarian stimulation on the expression of developmentally important reprogramming genes <i>(Apex1, Lig1, Lig3, Mbd2, Mbd3, Mbd4, </i>and<i> Polb)</i> in single early mouse morula embryos (16-cell stage). Using absolute quantification of mRNA by quantitati…

Malemedicine.medical_specialtyTime FactorsGonadotropins EquineDown-RegulationStimulationReproductive technologyBiologyChorionic GonadotropinMBD4AndrologyMiceOogenesisOvulation InductionInternal medicineGeneticsmedicineDNA-(Apurinic or Apyrimidinic Site) LyaseAnimalsHumansHorsesRNA MessengerMolecular BiologyGenetics (clinical)GametogenesisDNA Polymerase betaRegulation of gene expressionReverse Transcriptase Polymerase Chain ReactionEmbryogenesisGene Expression Regulation DevelopmentalEmbryoDNA-Binding ProteinsMice Inbred C57BLEndocrinologyBlastocystMicroscopy Fluorescenceembryonic structuresFemaleReprogrammingTranscription FactorsCytogenetic and genome research
researchProduct

Action of the racemate and the isomers of the platelet-activating factor antagonist bepafant (WEB 2170) after oral administration to guinea-pigs and …

1991

The aim of the present study was to clarify whether there is a difference in terms of potency and pharmacodynamic half time between the isomers and the racemate of the platelet-activating factor antagonist WEB 2170 (bepafant) after oral administration to guineapigs or rats. The following experiments were performed in the guinea-pig. Infusion of platelet-activating factor at 30 ng/ (kg × min) for 30 min to anaesthetized guinea-pigs induced a decrease of respiratory flow and mean arterial blood pressure. Oral pretreatment with WEB 2170 or isomers, respectively, 60 min before infusion of plateletactivating factor inhibited these changes in a dose-dependent manner. The ED50S for inhibition of r…

Malemedicine.medical_specialtyTime FactorsGuinea PigsAdministration OralBlood PressureGuinea pigStructure-Activity Relationshipchemistry.chemical_compoundOral administrationInternal medicinemedicineAnimalsPotencyPlatelet Activating FactorED50PharmacologyDose-Response Relationship DrugPlatelet-activating factorChemistryAntagonistRats Inbred StrainsStereoisomerismAzepinesGeneral MedicineTriazolesRatsEndocrinologyPharmacodynamicsPulmonary VentilationHalf timeNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct